Rochester, New York – Some newborn and child formula from Abbott is being recalled because the bottles’ closures may not close tightly enough to prevent spoiling.
The business asserted that Friday’s recall, despite its tiny size, shouldn’t lead to another statewide baby formula scarcity.
“This recall equates to less than one day’s worth of the total number of ounces of infant formula fed in the U.S. and is not expected to impact the overall U.S. infant supply,” according to Illinois-based Abbott, the largest U.S. formula manufacturer.
The Ready-to-Feed liquid solutions for newborns and children packaged in 2 fluid ounce/59-milliliter bottles are being recalled in some lots. If ingested, the formula may result in diarrhea and vomiting, according to Abbott.
The recalled products include Similac Pro-Total ComfortTM, Similac 360 Total Care, Similac 360 Total Care Sensitive, Similac Special Care 24, Similac Stage 1, Similac NeoSure, Similac Water (sterilized), Pedialyte Electrolyte Solution, all of which are produced at Abbott’s manufacturing facility in Columbus, Ohio.
Abbott said that in addition to increasing production across its entire global network, Similac infant formula is still available for purchase at retail establishments in a variety of product sizes, and Similac products are still produced for hospitals and other healthcare facilities on a different production line.
The majority of the hospitals, medical practices, and shops in the United States, including Puerto Rico, received the recalled goods. Two lots were transported to Canada, Curacao, Panama, Trinidad & Tobago, Bermuda, Barbados, Bermuda, Colombia, the Dominican Republic, Haiti, Jamaica, St. Croix, and St. Thomas.
Customers who purchased some of the recalled formula are advised not to use it and to visit similacrecall.com to examine a list of the affected lot numbers or to utilize the lot number checker.
Since February, when Abbott temporarily shut down its largest plant in Michigan and recalled several popular brands of formula, including Similac, many parents have experienced ongoing shortages of baby formula.
The plant’s closure coincided with a federal investigation into four infants who contracted bacterial infections after consuming powdered formula from the facility, two of whom passed away. The infections, which featured several bacterial strains, were not directly related to the company’s products, according to the business.
In the end, FDA investigators found numerous infractions at the facility, including bacterial contamination, a leaky roof, and weak safety procedures.